| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ischemia | 63 | 2025 | 370 | 13.480 |
Why?
|
| Peripheral Arterial Disease | 59 | 2025 | 322 | 11.520 |
Why?
|
| Diabetic Foot | 61 | 2025 | 168 | 10.790 |
Why?
|
| Limb Salvage | 53 | 2025 | 144 | 7.140 |
Why?
|
| Vascular Surgical Procedures | 52 | 2025 | 553 | 6.980 |
Why?
|
| Endovascular Procedures | 49 | 2025 | 788 | 5.640 |
Why?
|
| Lower Extremity | 25 | 2025 | 190 | 5.400 |
Why?
|
| Wound Healing | 33 | 2025 | 476 | 4.400 |
Why?
|
| Wound Infection | 9 | 2025 | 56 | 2.550 |
Why?
|
| Blood Vessel Prosthesis Implantation | 19 | 2020 | 788 | 2.310 |
Why?
|
| Arterial Occlusive Diseases | 8 | 2019 | 119 | 2.180 |
Why?
|
| Leg | 10 | 2023 | 132 | 2.150 |
Why?
|
| Treatment Outcome | 84 | 2025 | 13034 | 1.910 |
Why?
|
| Diabetic Angiopathies | 7 | 2023 | 71 | 1.850 |
Why?
|
| Risk Factors | 65 | 2025 | 10946 | 1.810 |
Why?
|
| Foot Ulcer | 8 | 2023 | 19 | 1.770 |
Why?
|
| Vascular Patency | 20 | 2020 | 188 | 1.760 |
Why?
|
| Foot | 9 | 2025 | 64 | 1.680 |
Why?
|
| Time Factors | 49 | 2025 | 6448 | 1.570 |
Why?
|
| Risk Assessment | 35 | 2025 | 3739 | 1.570 |
Why?
|
| Peripheral Vascular Diseases | 8 | 2023 | 80 | 1.570 |
Why?
|
| Vascular Grafting | 6 | 2025 | 50 | 1.480 |
Why?
|
| Stents | 16 | 2023 | 869 | 1.450 |
Why?
|
| Angioplasty, Balloon | 4 | 2019 | 156 | 1.430 |
Why?
|
| Humans | 200 | 2025 | 132089 | 1.410 |
Why?
|
| Decision Support Techniques | 6 | 2025 | 310 | 1.340 |
Why?
|
| Predictive Value of Tests | 17 | 2025 | 2322 | 1.340 |
Why?
|
| Evidence-Based Medicine | 8 | 2024 | 663 | 1.330 |
Why?
|
| Arteriovenous Shunt, Surgical | 7 | 2023 | 96 | 1.320 |
Why?
|
| Aged | 77 | 2025 | 21438 | 1.280 |
Why?
|
| Aneurysm | 3 | 2017 | 82 | 1.260 |
Why?
|
| Aortic Aneurysm, Abdominal | 8 | 2022 | 426 | 1.210 |
Why?
|
| Terminology as Topic | 4 | 2019 | 232 | 1.190 |
Why?
|
| Diabetes Mellitus | 11 | 2023 | 923 | 1.170 |
Why?
|
| Middle Aged | 76 | 2025 | 28998 | 1.160 |
Why?
|
| Severity of Illness Index | 18 | 2025 | 3092 | 1.140 |
Why?
|
| Chronic Disease | 18 | 2025 | 1234 | 1.130 |
Why?
|
| Tibial Arteries | 5 | 2012 | 8 | 1.090 |
Why?
|
| Mesenteric Ischemia | 3 | 2018 | 30 | 1.080 |
Why?
|
| Aged, 80 and over | 40 | 2025 | 7104 | 1.070 |
Why?
|
| Vascular System Injuries | 6 | 2021 | 59 | 1.070 |
Why?
|
| Veins | 6 | 2025 | 104 | 1.060 |
Why?
|
| Retrospective Studies | 53 | 2025 | 17416 | 1.050 |
Why?
|
| Intermittent Claudication | 8 | 2022 | 60 | 1.010 |
Why?
|
| Iliac Artery | 3 | 2019 | 75 | 1.000 |
Why?
|
| Iliac Aneurysm | 4 | 2011 | 29 | 0.980 |
Why?
|
| Male | 99 | 2025 | 64967 | 0.980 |
Why?
|
| Popliteal Artery | 7 | 2025 | 41 | 0.950 |
Why?
|
| Saphenous Vein | 5 | 2025 | 53 | 0.950 |
Why?
|
| Postoperative Complications | 15 | 2025 | 3142 | 0.930 |
Why?
|
| Anemia | 2 | 2019 | 350 | 0.880 |
Why?
|
| Podiatry | 5 | 2016 | 7 | 0.860 |
Why?
|
| Cardiac Rehabilitation | 3 | 2023 | 29 | 0.860 |
Why?
|
| Aneurysm, Infected | 3 | 2009 | 24 | 0.850 |
Why?
|
| Practice Guidelines as Topic | 12 | 2024 | 1303 | 0.850 |
Why?
|
| Femoral Artery | 8 | 2022 | 166 | 0.840 |
Why?
|
| Celiac Artery | 4 | 2018 | 31 | 0.820 |
Why?
|
| Practice Patterns, Physicians' | 7 | 2021 | 768 | 0.820 |
Why?
|
| Female | 89 | 2025 | 70695 | 0.810 |
Why?
|
| Arteries | 6 | 2023 | 222 | 0.800 |
Why?
|
| Phosphoproteins | 1 | 2025 | 442 | 0.790 |
Why?
|
| Ultrasonography, Doppler, Duplex | 7 | 2013 | 41 | 0.750 |
Why?
|
| Specialties, Surgical | 6 | 2020 | 91 | 0.740 |
Why?
|
| Patient Care Team | 7 | 2012 | 572 | 0.740 |
Why?
|
| Drug-Eluting Stents | 3 | 2020 | 69 | 0.740 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2025 | 270 | 0.740 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 143 | 0.720 |
Why?
|
| Renal Dialysis | 5 | 2019 | 948 | 0.720 |
Why?
|
| Cardiovascular Diseases | 7 | 2025 | 2092 | 0.710 |
Why?
|
| Toes | 4 | 2024 | 27 | 0.700 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 604 | 0.680 |
Why?
|
| Health Care Costs | 3 | 2025 | 414 | 0.670 |
Why?
|
| Extremities | 2 | 2020 | 82 | 0.660 |
Why?
|
| Leg Ulcer | 3 | 2023 | 11 | 0.640 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2019 | 516 | 0.620 |
Why?
|
| Kaplan-Meier Estimate | 12 | 2024 | 1132 | 0.620 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2019 | 36 | 0.620 |
Why?
|
| Constriction, Pathologic | 4 | 2015 | 236 | 0.610 |
Why?
|
| Mesenteric Artery, Superior | 2 | 2018 | 34 | 0.610 |
Why?
|
| Societies, Medical | 9 | 2021 | 779 | 0.610 |
Why?
|
| Vascular Access Devices | 1 | 2019 | 37 | 0.600 |
Why?
|
| Carotid Stenosis | 2 | 2019 | 123 | 0.600 |
Why?
|
| Paclitaxel | 1 | 2019 | 140 | 0.580 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 88 | 0.580 |
Why?
|
| Angioplasty | 4 | 2013 | 76 | 0.580 |
Why?
|
| Ankle Brachial Index | 7 | 2025 | 45 | 0.570 |
Why?
|
| Upper Extremity | 2 | 2009 | 56 | 0.570 |
Why?
|
| Myocardial Infarction | 4 | 2022 | 1047 | 0.570 |
Why?
|
| Patient Participation | 1 | 2020 | 240 | 0.550 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 237 | 0.550 |
Why?
|
| Femoral Vein | 2 | 2017 | 48 | 0.550 |
Why?
|
| Axillary Artery | 3 | 2015 | 30 | 0.520 |
Why?
|
| General Surgery | 1 | 2019 | 227 | 0.520 |
Why?
|
| Patient Selection | 7 | 2021 | 737 | 0.520 |
Why?
|
| Logistic Models | 10 | 2019 | 1839 | 0.520 |
Why?
|
| Aneurysm, False | 2 | 2023 | 91 | 0.520 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2016 | 20 | 0.510 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2018 | 221 | 0.500 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2017 | 302 | 0.480 |
Why?
|
| Attitude of Health Personnel | 2 | 2021 | 724 | 0.470 |
Why?
|
| Regional Blood Flow | 9 | 2025 | 212 | 0.470 |
Why?
|
| Aorta, Thoracic | 3 | 2022 | 540 | 0.450 |
Why?
|
| Resuscitation Orders | 1 | 2015 | 32 | 0.450 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 900 | 0.450 |
Why?
|
| Critical Illness | 9 | 2019 | 618 | 0.450 |
Why?
|
| Caregivers | 1 | 2020 | 595 | 0.450 |
Why?
|
| Vascular Diseases | 3 | 2021 | 150 | 0.440 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 408 | 0.440 |
Why?
|
| Odds Ratio | 6 | 2018 | 1254 | 0.440 |
Why?
|
| United States | 28 | 2023 | 11667 | 0.440 |
Why?
|
| Metatarsal Bones | 2 | 2022 | 8 | 0.430 |
Why?
|
| Length of Stay | 9 | 2020 | 1380 | 0.430 |
Why?
|
| Vena Cava, Inferior | 2 | 2018 | 105 | 0.430 |
Why?
|
| Popliteal Vein | 1 | 2013 | 8 | 0.430 |
Why?
|
| Fractures, Closed | 1 | 2013 | 9 | 0.420 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2014 | 2169 | 0.420 |
Why?
|
| Prosthesis Design | 8 | 2020 | 670 | 0.410 |
Why?
|
| Patient Readmission | 3 | 2018 | 425 | 0.410 |
Why?
|
| Chi-Square Distribution | 9 | 2018 | 589 | 0.400 |
Why?
|
| Monitoring, Physiologic | 3 | 2020 | 377 | 0.400 |
Why?
|
| Perfusion Imaging | 1 | 2013 | 13 | 0.400 |
Why?
|
| Tibial Fractures | 1 | 2013 | 63 | 0.390 |
Why?
|
| Prognosis | 11 | 2023 | 5014 | 0.390 |
Why?
|
| Occlusive Dressings | 4 | 2009 | 6 | 0.390 |
Why?
|
| Coloring Agents | 1 | 2013 | 76 | 0.390 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 1410 | 0.390 |
Why?
|
| Heart Diseases | 1 | 2017 | 513 | 0.390 |
Why?
|
| Education, Medical, Graduate | 3 | 2012 | 558 | 0.380 |
Why?
|
| Metatarsophalangeal Joint | 1 | 2012 | 3 | 0.380 |
Why?
|
| Indocyanine Green | 1 | 2013 | 63 | 0.380 |
Why?
|
| Gangrene | 4 | 2023 | 27 | 0.380 |
Why?
|
| Research Design | 3 | 2025 | 742 | 0.380 |
Why?
|
| Reproducibility of Results | 8 | 2025 | 3011 | 0.380 |
Why?
|
| Precision Medicine | 1 | 2016 | 360 | 0.380 |
Why?
|
| Arthroplasty | 1 | 2012 | 17 | 0.380 |
Why?
|
| Surgical Wound Infection | 2 | 2012 | 273 | 0.380 |
Why?
|
| Reoperation | 8 | 2013 | 853 | 0.370 |
Why?
|
| Joint Diseases | 1 | 2012 | 34 | 0.370 |
Why?
|
| Aortic Diseases | 2 | 2019 | 196 | 0.370 |
Why?
|
| Registries | 11 | 2025 | 1581 | 0.370 |
Why?
|
| Radiography | 8 | 2015 | 819 | 0.360 |
Why?
|
| Quality Indicators, Health Care | 3 | 2020 | 235 | 0.350 |
Why?
|
| Fluorescein Angiography | 1 | 2012 | 152 | 0.340 |
Why?
|
| Proportional Hazards Models | 8 | 2024 | 1460 | 0.340 |
Why?
|
| International Cooperation | 3 | 2020 | 165 | 0.340 |
Why?
|
| Mammary Arteries | 1 | 2010 | 29 | 0.340 |
Why?
|
| Aneurysm, Ruptured | 1 | 2010 | 35 | 0.330 |
Why?
|
| Wounds, Penetrating | 2 | 2023 | 142 | 0.330 |
Why?
|
| Recurrence | 6 | 2025 | 1469 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2020 | 861 | 0.320 |
Why?
|
| Balloon Occlusion | 2 | 2009 | 48 | 0.320 |
Why?
|
| Endocrinology | 3 | 2010 | 128 | 0.320 |
Why?
|
| Hospital Mortality | 7 | 2019 | 1057 | 0.310 |
Why?
|
| Frail Elderly | 3 | 2020 | 107 | 0.300 |
Why?
|
| Frailty | 2 | 2022 | 136 | 0.300 |
Why?
|
| Hemostasis | 1 | 2009 | 73 | 0.300 |
Why?
|
| Atherectomy | 1 | 2008 | 12 | 0.300 |
Why?
|
| Secondary Prevention | 2 | 2025 | 223 | 0.300 |
Why?
|
| Glomus Tumor | 1 | 2008 | 13 | 0.290 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 324 | 0.290 |
Why?
|
| Marfan Syndrome | 1 | 2010 | 148 | 0.290 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2014 | 705 | 0.290 |
Why?
|
| Cost-Benefit Analysis | 4 | 2025 | 576 | 0.290 |
Why?
|
| Survival Rate | 5 | 2025 | 2194 | 0.290 |
Why?
|
| Adult | 26 | 2025 | 31575 | 0.280 |
Why?
|
| Intestinal Fistula | 1 | 2008 | 29 | 0.280 |
Why?
|
| Arizona | 6 | 2015 | 27 | 0.280 |
Why?
|
| Databases, Factual | 6 | 2025 | 1229 | 0.280 |
Why?
|
| Foot Diseases | 2 | 2023 | 23 | 0.270 |
Why?
|
| Vascular Fistula | 1 | 2008 | 31 | 0.270 |
Why?
|
| Colonic Diseases | 1 | 2008 | 38 | 0.270 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 143 | 0.270 |
Why?
|
| Surgical Procedures, Operative | 2 | 2021 | 223 | 0.270 |
Why?
|
| Internship and Residency | 3 | 2012 | 1247 | 0.270 |
Why?
|
| Follow-Up Studies | 10 | 2025 | 5416 | 0.260 |
Why?
|
| Treatment Failure | 5 | 2009 | 366 | 0.260 |
Why?
|
| Healthcare Disparities | 3 | 2017 | 487 | 0.260 |
Why?
|
| Prevalence | 7 | 2025 | 2658 | 0.260 |
Why?
|
| United Kingdom | 4 | 2025 | 235 | 0.260 |
Why?
|
| Aorta, Abdominal | 2 | 2018 | 118 | 0.260 |
Why?
|
| Median Arcuate Ligament Syndrome | 2 | 2017 | 5 | 0.260 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 1439 | 0.260 |
Why?
|
| Aortic Aneurysm | 1 | 2009 | 237 | 0.260 |
Why?
|
| Delphi Technique | 2 | 2025 | 241 | 0.250 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2016 | 51 | 0.250 |
Why?
|
| Sepsis | 3 | 2015 | 515 | 0.250 |
Why?
|
| User-Computer Interface | 2 | 2020 | 171 | 0.250 |
Why?
|
| Trauma Centers | 3 | 2017 | 199 | 0.240 |
Why?
|
| Physical Examination | 3 | 2014 | 165 | 0.240 |
Why?
|
| Incidence | 6 | 2021 | 3379 | 0.230 |
Why?
|
| Aortic Rupture | 2 | 2022 | 119 | 0.230 |
Why?
|
| Blood Transfusion | 3 | 2017 | 291 | 0.230 |
Why?
|
| Propensity Score | 4 | 2025 | 257 | 0.230 |
Why?
|
| Conservative Treatment | 1 | 2025 | 41 | 0.230 |
Why?
|
| Gait | 2 | 2016 | 142 | 0.230 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 573 | 0.220 |
Why?
|
| Rivaroxaban | 2 | 2022 | 57 | 0.220 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 465 | 0.220 |
Why?
|
| Editorial Policies | 1 | 2024 | 50 | 0.210 |
Why?
|
| Embolism | 1 | 2024 | 46 | 0.210 |
Why?
|
| Amyloidosis | 1 | 2025 | 74 | 0.210 |
Why?
|
| Biomedical Research | 2 | 2024 | 555 | 0.210 |
Why?
|
| Cell Division | 1 | 2025 | 743 | 0.210 |
Why?
|
| Thromboangiitis Obliterans | 1 | 2003 | 1 | 0.210 |
Why?
|
| Total Quality Management | 1 | 2003 | 25 | 0.210 |
Why?
|
| Texas | 5 | 2022 | 3629 | 0.210 |
Why?
|
| Emergencies | 2 | 2015 | 186 | 0.200 |
Why?
|
| Aspirin | 2 | 2022 | 220 | 0.200 |
Why?
|
| Sex Distribution | 2 | 2021 | 328 | 0.200 |
Why?
|
| Publishing | 1 | 2024 | 106 | 0.200 |
Why?
|
| Early Ambulation | 1 | 2022 | 9 | 0.200 |
Why?
|
| Pandemics | 2 | 2021 | 1183 | 0.200 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2019 | 86 | 0.200 |
Why?
|
| Retreatment | 3 | 2019 | 93 | 0.200 |
Why?
|
| Elective Surgical Procedures | 3 | 2025 | 161 | 0.200 |
Why?
|
| Cell Cycle | 1 | 2025 | 611 | 0.200 |
Why?
|
| Negative-Pressure Wound Therapy | 4 | 2010 | 19 | 0.190 |
Why?
|
| Research | 2 | 2023 | 265 | 0.190 |
Why?
|
| Consensus | 5 | 2023 | 651 | 0.190 |
Why?
|
| Arm | 1 | 2002 | 77 | 0.190 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 569 | 0.180 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 191 | 0.180 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 698 | 0.180 |
Why?
|
| Scholarly Communication | 1 | 2021 | 7 | 0.180 |
Why?
|
| Periodicals as Topic | 1 | 2024 | 186 | 0.180 |
Why?
|
| Hemangiosarcoma | 1 | 2022 | 45 | 0.180 |
Why?
|
| Disease-Free Survival | 4 | 2018 | 959 | 0.180 |
Why?
|
| Markov Chains | 2 | 2025 | 101 | 0.180 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2025 | 245 | 0.170 |
Why?
|
| Certification | 2 | 2020 | 72 | 0.170 |
Why?
|
| Computed Tomography Angiography | 3 | 2018 | 215 | 0.170 |
Why?
|
| Congresses as Topic | 3 | 2019 | 186 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 897 | 0.170 |
Why?
|
| Biomarkers | 4 | 2020 | 3407 | 0.170 |
Why?
|
| Iatrogenic Disease | 1 | 2021 | 132 | 0.170 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 44 | 0.170 |
Why?
|
| Hospitals | 2 | 2022 | 438 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 1 | 2025 | 378 | 0.170 |
Why?
|
| Pilot Projects | 3 | 2025 | 1444 | 0.170 |
Why?
|
| Global Health | 3 | 2020 | 644 | 0.160 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 199 | 0.160 |
Why?
|
| Judgment | 1 | 2020 | 38 | 0.160 |
Why?
|
| Sex Factors | 4 | 2024 | 1355 | 0.160 |
Why?
|
| Injury Severity Score | 3 | 2017 | 230 | 0.160 |
Why?
|
| Forecasting | 2 | 2019 | 371 | 0.160 |
Why?
|
| Prospective Studies | 9 | 2025 | 6572 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2025 | 57 | 0.160 |
Why?
|
| Exercise Therapy | 2 | 2022 | 182 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 1248 | 0.160 |
Why?
|
| Professional-Patient Relations | 1 | 2020 | 92 | 0.160 |
Why?
|
| Telemedicine | 2 | 2018 | 495 | 0.160 |
Why?
|
| Clinical Competence | 3 | 2020 | 1068 | 0.160 |
Why?
|
| Clinical Decision-Making | 2 | 2019 | 307 | 0.160 |
Why?
|
| Young Adult | 7 | 2019 | 9958 | 0.160 |
Why?
|
| Centralized Hospital Services | 1 | 2019 | 5 | 0.160 |
Why?
|
| Regional Health Planning | 1 | 2019 | 6 | 0.160 |
Why?
|
| Home Care Services | 1 | 2020 | 75 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2008 | 845 | 0.150 |
Why?
|
| Collateral Circulation | 2 | 2017 | 43 | 0.150 |
Why?
|
| Social Media | 1 | 2021 | 121 | 0.150 |
Why?
|
| Health Services Research | 1 | 2020 | 186 | 0.150 |
Why?
|
| Wearable Electronic Devices | 1 | 2020 | 108 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2024 | 1400 | 0.150 |
Why?
|
| Postoperative Care | 3 | 2018 | 312 | 0.150 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 141 | 0.150 |
Why?
|
| Endarterectomy, Carotid | 1 | 2019 | 83 | 0.140 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2022 | 302 | 0.140 |
Why?
|
| Preventive Health Services | 1 | 2019 | 63 | 0.140 |
Why?
|
| Medical History Taking | 3 | 2014 | 114 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2025 | 743 | 0.140 |
Why?
|
| Catheters, Indwelling | 1 | 2019 | 157 | 0.140 |
Why?
|
| Vital Signs | 1 | 2018 | 27 | 0.140 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 1163 | 0.140 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2018 | 25 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2022 | 289 | 0.140 |
Why?
|
| Benchmarking | 3 | 2021 | 138 | 0.140 |
Why?
|
| Thoracic Injuries | 1 | 2018 | 90 | 0.140 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3681 | 0.140 |
Why?
|
| Ankle Joint | 1 | 2017 | 35 | 0.140 |
Why?
|
| Walking | 2 | 2016 | 234 | 0.130 |
Why?
|
| Ligation | 2 | 2011 | 140 | 0.130 |
Why?
|
| Age Factors | 4 | 2017 | 2916 | 0.130 |
Why?
|
| Mesenteric Arteries | 1 | 2017 | 51 | 0.130 |
Why?
|
| Splanchnic Circulation | 1 | 2017 | 51 | 0.130 |
Why?
|
| Hemodynamics | 3 | 2025 | 852 | 0.130 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 80 | 0.130 |
Why?
|
| Abdominal Injuries | 1 | 2018 | 117 | 0.130 |
Why?
|
| Angiography | 2 | 2017 | 208 | 0.130 |
Why?
|
| Computer Simulation | 2 | 2019 | 697 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2022 | 716 | 0.130 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 4 | 0.130 |
Why?
|
| Regional Medical Programs | 1 | 2016 | 18 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 485 | 0.130 |
Why?
|
| Diabetes Complications | 3 | 2014 | 207 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2020 | 669 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2024 | 2140 | 0.130 |
Why?
|
| Video Games | 1 | 2017 | 98 | 0.130 |
Why?
|
| Models, Economic | 1 | 2016 | 61 | 0.120 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2016 | 46 | 0.120 |
Why?
|
| Arteriosclerosis Obliterans | 1 | 2016 | 1 | 0.120 |
Why?
|
| Cost Savings | 1 | 2016 | 78 | 0.120 |
Why?
|
| Hemoglobins | 1 | 2017 | 322 | 0.120 |
Why?
|
| Communication | 1 | 2020 | 543 | 0.120 |
Why?
|
| Debridement | 3 | 2010 | 92 | 0.120 |
Why?
|
| Depression | 1 | 2025 | 1342 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 172 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 729 | 0.120 |
Why?
|
| Alloys | 2 | 2013 | 15 | 0.120 |
Why?
|
| Transducers | 1 | 2015 | 22 | 0.120 |
Why?
|
| Adolescent | 8 | 2022 | 20560 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2007 | 166 | 0.120 |
Why?
|
| Subclavian Artery | 1 | 2015 | 70 | 0.120 |
Why?
|
| Vocabulary, Controlled | 1 | 2015 | 13 | 0.120 |
Why?
|
| Disease Progression | 3 | 2025 | 2225 | 0.120 |
Why?
|
| Academic Medical Centers | 2 | 2015 | 333 | 0.110 |
Why?
|
| Europe | 3 | 2024 | 372 | 0.110 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 3766 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2017 | 260 | 0.110 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 133 | 0.110 |
Why?
|
| Oxygen | 2 | 2016 | 571 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 380 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 391 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 81 | 0.110 |
Why?
|
| Postural Balance | 1 | 2015 | 131 | 0.110 |
Why?
|
| Patient Safety | 1 | 2019 | 440 | 0.110 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 289 | 0.110 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 504 | 0.110 |
Why?
|
| Exercise | 1 | 2020 | 858 | 0.110 |
Why?
|
| Oximetry | 1 | 2015 | 178 | 0.110 |
Why?
|
| Acellular Dermis | 1 | 2013 | 7 | 0.110 |
Why?
|
| Models, Biological | 1 | 2019 | 1443 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 669 | 0.110 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 1294 | 0.110 |
Why?
|
| Disease Management | 2 | 2020 | 563 | 0.100 |
Why?
|
| Cardiology | 1 | 2019 | 498 | 0.100 |
Why?
|
| Faculty, Medical | 1 | 2017 | 277 | 0.100 |
Why?
|
| Skin Transplantation | 1 | 2014 | 54 | 0.100 |
Why?
|
| Ambulatory Care | 1 | 2017 | 410 | 0.100 |
Why?
|
| Therapeutic Irrigation | 2 | 2010 | 45 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2017 | 523 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 69 | 0.100 |
Why?
|
| Point-of-Care Testing | 2 | 2023 | 33 | 0.100 |
Why?
|
| Patient Admission | 1 | 2014 | 185 | 0.100 |
Why?
|
| Tissue Scaffolds | 1 | 2013 | 78 | 0.100 |
Why?
|
| Embolization, Therapeutic | 2 | 2017 | 223 | 0.100 |
Why?
|
| Hospital Costs | 1 | 2014 | 187 | 0.100 |
Why?
|
| Child | 7 | 2023 | 25786 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 237 | 0.100 |
Why?
|
| Linear Models | 1 | 2014 | 713 | 0.090 |
Why?
|
| Remission Induction | 1 | 2013 | 307 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2012 | 69 | 0.090 |
Why?
|
| Pneumonia | 1 | 2015 | 334 | 0.090 |
Why?
|
| Knowledge | 1 | 2011 | 51 | 0.090 |
Why?
|
| Equipment Design | 2 | 2015 | 603 | 0.090 |
Why?
|
| Tibia | 1 | 2012 | 80 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 1035 | 0.090 |
Why?
|
| Brachial Artery | 2 | 2008 | 40 | 0.090 |
Why?
|
| Emergency Service, Hospital | 2 | 2017 | 1170 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2016 | 699 | 0.080 |
Why?
|
| Neoplasms | 1 | 2025 | 2957 | 0.080 |
Why?
|
| Feasibility Studies | 3 | 2019 | 824 | 0.080 |
Why?
|
| Life Tables | 2 | 2017 | 28 | 0.080 |
Why?
|
| Career Choice | 1 | 2011 | 160 | 0.080 |
Why?
|
| Biopsy | 1 | 2013 | 1284 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 3 | 2019 | 951 | 0.080 |
Why?
|
| Methacrylates | 1 | 2009 | 18 | 0.080 |
Why?
|
| Acute Disease | 2 | 2024 | 1160 | 0.080 |
Why?
|
| ROC Curve | 2 | 2025 | 601 | 0.080 |
Why?
|
| Aorta | 2 | 2023 | 550 | 0.080 |
Why?
|
| Comorbidity | 1 | 2014 | 1611 | 0.080 |
Why?
|
| Product Labeling | 1 | 2008 | 4 | 0.070 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2009 | 30 | 0.070 |
Why?
|
| Endarterectomy | 1 | 2008 | 25 | 0.070 |
Why?
|
| Cooperative Behavior | 3 | 2019 | 232 | 0.070 |
Why?
|
| Thigh | 1 | 2008 | 51 | 0.070 |
Why?
|
| Indium Radioisotopes | 1 | 2008 | 7 | 0.070 |
Why?
|
| Wounds, Gunshot | 1 | 2009 | 145 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 893 | 0.070 |
Why?
|
| Forearm | 1 | 2008 | 39 | 0.070 |
Why?
|
| Stroke | 1 | 2016 | 1085 | 0.070 |
Why?
|
| Diabetic Neuropathies | 1 | 2008 | 56 | 0.070 |
Why?
|
| Hospitals, High-Volume | 2 | 2019 | 41 | 0.070 |
Why?
|
| Colectomy | 1 | 2008 | 84 | 0.070 |
Why?
|
| Hand | 1 | 2008 | 106 | 0.070 |
Why?
|
| Coronary Restenosis | 1 | 2007 | 25 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 3 | 2010 | 2555 | 0.060 |
Why?
|
| Polytetrafluoroethylene | 2 | 2008 | 66 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 393 | 0.060 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2008 | 197 | 0.060 |
Why?
|
| Surgical Flaps | 1 | 2008 | 189 | 0.060 |
Why?
|
| Blood Flow Velocity | 3 | 2017 | 440 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 482 | 0.060 |
Why?
|
| Glasgow Coma Scale | 2 | 2017 | 200 | 0.060 |
Why?
|
| Device Removal | 1 | 2008 | 227 | 0.060 |
Why?
|
| Infant | 3 | 2018 | 13061 | 0.060 |
Why?
|
| Brachytherapy | 1 | 2007 | 95 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2020 | 5168 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 2007 | 136 | 0.060 |
Why?
|
| Colonoscopy | 1 | 2008 | 252 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2018 | 14749 | 0.060 |
Why?
|
| England | 1 | 2025 | 62 | 0.060 |
Why?
|
| Insulin | 1 | 2010 | 1168 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2013 | 1008 | 0.060 |
Why?
|
| Administration, Topical | 3 | 2010 | 140 | 0.060 |
Why?
|
| Stomach | 1 | 2007 | 273 | 0.060 |
Why?
|
| Renal Artery Obstruction | 1 | 2005 | 42 | 0.060 |
Why?
|
| Intention to Treat Analysis | 1 | 2024 | 63 | 0.060 |
Why?
|
| Patient Care Planning | 1 | 2005 | 130 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2025 | 141 | 0.060 |
Why?
|
| Vacuum | 1 | 2004 | 11 | 0.050 |
Why?
|
| Fasciotomy | 1 | 2024 | 26 | 0.050 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 4003 | 0.050 |
Why?
|
| Contraindications | 1 | 2004 | 79 | 0.050 |
Why?
|
| Focus Groups | 1 | 2025 | 224 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 116 | 0.050 |
Why?
|
| Long-Term Care | 1 | 2003 | 73 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2016 | 3416 | 0.050 |
Why?
|
| Nutrition Policy | 1 | 2023 | 91 | 0.050 |
Why?
|
| Health Priorities | 1 | 2023 | 37 | 0.050 |
Why?
|
| Probability | 1 | 2003 | 322 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2025 | 462 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2022 | 62 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 707 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2004 | 211 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2023 | 294 | 0.050 |
Why?
|
| American Heart Association | 1 | 2023 | 309 | 0.050 |
Why?
|
| Doxycycline | 1 | 2002 | 120 | 0.040 |
Why?
|
| Catheterization | 1 | 2023 | 241 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2023 | 311 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2025 | 606 | 0.040 |
Why?
|
| Attitude to Computers | 1 | 2021 | 48 | 0.040 |
Why?
|
| Patient Advocacy | 1 | 2021 | 63 | 0.040 |
Why?
|
| Conflict of Interest | 1 | 2021 | 67 | 0.040 |
Why?
|
| Pancreatectomy | 1 | 2022 | 149 | 0.040 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2022 | 106 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2003 | 368 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2024 | 256 | 0.040 |
Why?
|
| Pancreas | 1 | 2022 | 222 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2020 | 48 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2020 | 72 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2021 | 271 | 0.040 |
Why?
|
| Therapies, Investigational | 1 | 2020 | 13 | 0.040 |
Why?
|
| Metals | 1 | 2020 | 66 | 0.040 |
Why?
|
| Risk | 2 | 2015 | 761 | 0.040 |
Why?
|
| Spatial Analysis | 1 | 2019 | 27 | 0.040 |
Why?
|
| Hospitals, Low-Volume | 1 | 2019 | 32 | 0.040 |
Why?
|
| Review Literature as Topic | 1 | 2020 | 49 | 0.040 |
Why?
|
| Transportation | 1 | 2019 | 29 | 0.040 |
Why?
|
| Geography | 1 | 2019 | 123 | 0.040 |
Why?
|
| Interdisciplinary Communication | 2 | 2010 | 133 | 0.040 |
Why?
|
| Organ Sparing Treatments | 1 | 2019 | 43 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2019 | 56 | 0.040 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 28 | 0.040 |
Why?
|
| Global Burden of Disease | 1 | 2019 | 34 | 0.040 |
Why?
|
| Thrombosis | 1 | 2024 | 524 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2020 | 334 | 0.040 |
Why?
|
| Workload | 2 | 2011 | 151 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 519 | 0.040 |
Why?
|
| Informed Consent | 1 | 2021 | 347 | 0.040 |
Why?
|
| North America | 1 | 2019 | 265 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 690 | 0.040 |
Why?
|
| Biofeedback, Psychology | 1 | 2017 | 38 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2014 | 568 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2025 | 672 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2017 | 82 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 152 | 0.030 |
Why?
|
| Electromyography | 1 | 2017 | 141 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 229 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2019 | 215 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 186 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 299 | 0.030 |
Why?
|
| Walking Speed | 1 | 2016 | 19 | 0.030 |
Why?
|
| Accelerometry | 1 | 2016 | 64 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 294 | 0.030 |
Why?
|
| Torso | 1 | 2015 | 13 | 0.030 |
Why?
|
| Ankle | 1 | 2016 | 29 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2015 | 142 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 2015 | 58 | 0.030 |
Why?
|
| Costa Rica | 1 | 2015 | 15 | 0.030 |
Why?
|
| Miniaturization | 1 | 2015 | 26 | 0.030 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2015 | 69 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2016 | 355 | 0.030 |
Why?
|
| Hypesthesia | 1 | 2014 | 11 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 86 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 131 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1011 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 588 | 0.030 |
Why?
|
| Sirolimus | 1 | 2015 | 240 | 0.030 |
Why?
|
| Motor Activity | 1 | 2016 | 523 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2015 | 285 | 0.030 |
Why?
|
| Skin | 1 | 2016 | 527 | 0.020 |
Why?
|
| Medicaid | 1 | 2015 | 251 | 0.020 |
Why?
|
| Inpatients | 1 | 2017 | 552 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 902 | 0.020 |
Why?
|
| Medicare | 1 | 2015 | 448 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1573 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2017 | 1014 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1672 | 0.020 |
Why?
|
| Heart Failure | 1 | 2025 | 2393 | 0.020 |
Why?
|
| Operating Room Information Systems | 1 | 2010 | 1 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 672 | 0.020 |
Why?
|
| Infectious Disease Medicine | 1 | 2010 | 11 | 0.020 |
Why?
|
| Feedback | 1 | 2011 | 164 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2010 | 36 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 21 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2010 | 45 | 0.020 |
Why?
|
| Bandages | 1 | 2010 | 56 | 0.020 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 67 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 97 | 0.020 |
Why?
|
| Cotton Fiber | 1 | 2009 | 1 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 453 | 0.020 |
Why?
|
| Consumer Product Safety | 1 | 2009 | 31 | 0.020 |
Why?
|
| Powders | 1 | 2009 | 24 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 2161 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2011 | 330 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2010 | 385 | 0.020 |
Why?
|
| Groin | 1 | 2008 | 14 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 160 | 0.020 |
Why?
|
| Aging | 1 | 2015 | 1248 | 0.020 |
Why?
|
| Hospitalization | 1 | 2017 | 1900 | 0.020 |
Why?
|
| Learning | 1 | 2011 | 370 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2014 | 793 | 0.020 |
Why?
|
| Aortography | 1 | 2008 | 183 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2008 | 86 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2010 | 422 | 0.020 |
Why?
|
| Curriculum | 1 | 2011 | 772 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2008 | 187 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2007 | 183 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2008 | 270 | 0.010 |
Why?
|
| Hypertension, Renovascular | 1 | 2005 | 29 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2007 | 485 | 0.010 |
Why?
|
| Critical Care | 1 | 2008 | 686 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2002 | 137 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 252 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2002 | 473 | 0.010 |
Why?
|